Hasnain Faheem

Average Profitability
<0.0001%
Insider Buys Quantity
8
Insider Buys Sum
$7.51M
Insider Sells Quantity
7
Insider Sells Sum
$3.84M

Insider Activity of Hasnain Faheem

According to the SEC Form 4 filings, Hasnain Faheem, being in a position of

  1. President & CEO at Gossamer Bio, Inc.,
    оver the last 12 months, has bought 372000 shares for $250,282, and sold 23172 shares for $26,773,
    over all time since 2019-09-27, has bought 723736 shares for $3.42M, and sold 42207 shares for $196,470.

The largest purchase of all time was on 2017-04-19 and amounted to 200000 shares of Forte Biosciences, Inc. for $2M.

The largest sale of all time was on 2008-07-09 and amounted to 36837 shares of Biogen Inc. for $2.29M.

Biography of Hasnain Faheem

No biography is available at this moment.

2024-06-21PurchaseGossamer Bio, Inc.
GOSS
President & CEO
372,000
0.2168%
$0.67$250,282+43.08%
2024-03-27SaleGossamer Bio, Inc.
GOSS
President & CEO
23,172
0.0101%
$1.16$26,773-24.79%
2022-07-15PurchaseGossamer Bio, Inc.
GOSS
President & CEO
138,696
0.099%
$7.21$999,998-79.92%
2022-03-23SaleGossamer Bio, Inc.
GOSS
President & CEO
19,035
0.0254%
$8.91$169,697-4.09%
2020-10-14PurchaseGossamer Bio, Inc.
GOSS
director
193,040
0.3131%
$10.36$2M-1.07%
2019-09-27PurchaseGossamer Bio, Inc.
GOSS
director
20,000
0.0161%
$8.40$167,980-20.65%
2019-05-30PurchaseForte Biosciences, Inc.
FBRX
director
43,000
0.0242%
$4.66$200,315-77.34%
2018-09-13SaleImmunic, Inc.
IMUX
director
177,443
0.368%
$0.44$77,679-41.16%
2017-09-14PurchaseImmunic, Inc.
IMUX
director
118,400
0.2764%
$4.19$495,741+36.47%
2017-04-19PurchaseForte Biosciences, Inc.
FBRX
director
200,000
0.9793%
$10.00$2M-14.41%
2016-08-12PurchaseImmunic, Inc.
IMUX
director
236,486
0.717%
$5.92$1.4M-26.26%
2008-07-09SaleBiogen Inc.
BIIB
EVP, Oncology/Rheumatology SBU
36,837
0.0129%
$62.07$2.29M-19.57%
2008-04-08SaleBiogen Inc.
BIIB
EVP, Oncology/Rheumatology SBU
6,425
0.0022%
$64.68$415,582-22.7%
2007-05-23SaleBiogen Inc.
BIIB
EVP, Oncology/Rheumatology SBU
7,446
0.0022%
$49.00$364,854+27.36%
2006-10-02SaleBiogen Inc.
BIIB
EVP, Oncology/Rheumatology SBU
11,244
0.0034%
$44.63$501,797+11.89%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.